Rank;Global Rank;Institution;Country;Sector
1;62;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;186;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
3;207;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
4;227;Novo Nordisk A/S;DNK;Companies
5;265;Novartis, Switzerland;CHE;Companies
6;266;Merck KGaA, Germany;DEU;Companies
7;277;GlaxoSmithKline, United Kingdom;GBR;Companies
8;309;IMEC International;BEL;Companies
9;323;AstraZeneca, United Kingdom;GBR;Companies
10;384;Pfizer Inc., United Kingdom;GBR;Companies
11;450;GlaxoSmithKline, Belgium;BEL;Companies
12;455;Robert Bosch GmbH;DEU;Companies
13;476;AstraZeneca, Sweden;SWE;Companies
14;511;Bayer AG, Germany;DEU;Companies
15;840;France Telecom, S.A.;FRA;Companies
16;843;BMW AG;DEU;Companies
17;884;Daimler AG;DEU;Companies
18;1132;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
19;1174;Abengoa Solar;ESP;Companies
20;1803;SINTEF Group;NOR;Companies
21;2399;BMJ Group;GBR;Companies
22;2553;Sincrotrone Trieste;ITA;Companies
23;2672;European XFEL GmbH;DEU;Companies
24;3364;Electricite de France, S.A.;FRA;Companies